Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

European Journal of Pharmacology

Volumn 263, Issue 1-2, 1994, Pages 1-7

  Papp, Mariusz ^a   Moryl, Elzbieta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(Rat); Anhedonia; animal model; CGP 37849; CGP 40116; Depression; Imipramine; MK 801

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ANTIDEPRESSANT AGENT; DIZOCILPINE; IMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SUCROSE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE TIME EFFECT RELATION; ENANTIOMER; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STRESS;

2-AMINO-5-PHOSPHONOVALERATE; ANIMAL; DEPRESSION; DIZOCILPINE MALEATE; IMIPRAMINE; INJECTIONS, INTRAPERITONEAL; MALE; MODELS, BIOLOGICAL; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM; STRESS;

EID: 0027967222     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(94)90516-9     Document Type: Article

References (49)

1. 2+ levels in neuronal culture
2. Clinical and biochemical aspects of depressive disorders. II. Transmitter/receptor theories
3. The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole
4. Long-term imipramine effects are prevented by NMDA receptor blockade
5. 1A receptor anonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze
6. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-spartate receptor antagonists with oral activity
7. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects
8. Panic disorder: a biological perspective
9. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations
10. Effects of antidepressants on the glutamatergic system in mouse brain
11. 2 receptors in the chronic mild stress model of depression in rats
12. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
13. N-Methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis
14. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat
15. Tricyclic antidepressants block N-methyl-D-aspartic acid-induced lethality in mice
16. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine
17. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats
18. The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test
19. Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity
20. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters
21. Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats
22. Chronic administration of NMDA antagonists induces D-2 receptor synthesis in rat striatum
23. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats
24. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline
25. Adaptive changes in the N-methyl-D-aspartate receptor complex following chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid
26. MK-801 and enantiomers: potential antidepressants or false positives in classical screening models?
27. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
28. Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress
29. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine
30. Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists
31. Mechanisms of action of new antiepileptic drugs
32. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc
33. Differing effects of alpha-difluoromethyl-ornithine and CGP 40116 on polyamine levels and infarct volume in a rat model of focal cerebral ischaemia
34. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents
35. Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate
36. Sigma, PCP and glutamate sites as a novel target for antipsychotic drugs
37. The excitatory amino acid antagonists D-CPP-ene (SDZ EAA-494) in patients with epilepsy
38. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
39. 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models
40. Inhibition of N-methyl-D-aspartate activated ion current by desmethylimipramine
41. Phencyclidine-like discriminative stimulus properties of MK-801 in rats
42. The behavioral pharmacology of NMDA receptor antagonists
43. Animal models as simulations of depression
44. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant
45. Changes in mesolimbic dopamine may explain stress-induced anhedonia
46. Dopaminergic mechanisms in an animal model of depression
47. Chronic mild stress-induced anhedonia: a realistic animal model of depression
48. The anticonvulsant MK-801 is a potent N-emthyl-D-aspartate antagonists